0001209191-18-050061.txt : 20180907 0001209191-18-050061.hdr.sgml : 20180907 20180907162100 ACCESSION NUMBER: 0001209191-18-050061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180906 FILED AS OF DATE: 20180907 DATE AS OF CHANGE: 20180907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WU JINN CENTRAL INDEX KEY: 0001314254 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38112 FILM NUMBER: 181060390 MAIL ADDRESS: STREET 1: 107 MORGAN LANE CITY: PLAINSBORO STATE: NJ ZIP: 08536 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Athenex, Inc. CENTRAL INDEX KEY: 0001300699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 431985966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-898-8625 MAIL ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20131223 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC DATE OF NAME CHANGE: 20040817 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-06 0 0001300699 Athenex, Inc. ATNX 0001314254 WU JINN C/O ATHENEX, INC. 1001 MAIN STREET, SUITE 600 BUFFALO NY 14203 1 0 0 0 Common Stock 2018-09-06 4 P 0 2500 16.088 A 266708 D Stock Option (Right to Buy) 4.55 2021-05-09 Common Stock 16000 16000 D Stock Option (Right to Buy) 4.55 2022-03-26 Common Stock 16000 16000 D Stock Option (Right to Buy) 4.55 2013-01-02 2023-01-02 Common Stock 90000 90000 D Stock Option (Right to Buy) 4.55 2014-02-12 2024-02-12 Common Stock 10000 10000 D Stock Option (Right to Buy) 5.50 2015-02-05 2025-02-05 Common Stock 54000 54000 D Stock Option (Right to Buy) 5.50 2025-03-20 Common Stock 96000 96000 D Stock Option (Right to Buy) 11.00 2027-06-13 Common Stock 28500 28500 D This transaction was executed in multiple trades at prices ranging from $16.084 to $16.089. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. The option vested in two equal annual installments beginning on May 9, 2012. The option vested in full on March 26, 2013. The option vested in full on March 20, 2017. The option vests in four equal annual installments beginning on June 13, 2018. /s/ Teresa Bair, Attorney-in-Fact 2018-09-07